Compare NOC & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOC | ELV |
|---|---|---|
| Founded | 1939 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9B | 85.7B |
| IPO Year | 2002 | 2001 |
| Metric | NOC | ELV |
|---|---|---|
| Price | $552.77 | $388.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 19 |
| Target Price | ★ $697.38 | $383.56 |
| AVG Volume (30 Days) | 662.2K | ★ 1.5M |
| Earning Date | 04-21-2026 | 04-22-2026 |
| Dividend Yield | 1.61% | ★ 1.83% |
| EPS Growth | ★ 2.61 | N/A |
| EPS | 6.14 | ★ 8.00 |
| Revenue | $41,954,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $5.68 | N/A |
| Revenue Next Year | $6.20 | $3.07 |
| P/E Ratio | $90.79 | ★ $48.53 |
| Revenue Growth | 2.24 | ★ 12.49 |
| 52 Week Low | $468.50 | $273.71 |
| 52 Week High | $774.00 | $408.00 |
| Indicator | NOC | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 34.19 | 61.72 |
| Support Level | $541.33 | $307.16 |
| Resistance Level | $585.71 | N/A |
| Average True Range (ATR) | 10.05 | 9.94 |
| MACD | 5.11 | -2.61 |
| Stochastic Oscillator | 60.19 | 49.92 |
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment produces autonomous and piloted aircraft such as Global Hawk drones and the new B-21 bomber, creates the fuselage for the massive F-35 program, and maintains and upgrades numerous other military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.